Nektar Therapeutics
NKTR
$0.8968
$0.08149.98%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -37.06M | -52.36M | -36.80M | -42.08M | -45.84M |
| Total Depreciation and Amortization | 993.00K | 1.46M | 1.61M | 1.65M | 1.70M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -8.96M | 2.40M | -6.07M | -1.89M | 5.26M |
| Change in Net Operating Assets | 1.09M | 10.80M | -6.62M | -4.73M | -3.23M |
| Cash from Operations | -43.93M | -37.70M | -47.89M | -47.05M | -42.12M |
| Capital Expenditure | -666.00K | -186.00K | -157.00K | -237.00K | -33.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | 0.00 | 1.25M |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 46.78M | 17.17M | 19.42M | 17.62M | 55.20M |
| Cash from Investing | 46.12M | 16.98M | 19.26M | 17.38M | 56.41M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 13.00K | 19.00K | 3.00K | 12.00K | 0.00 |
| Repurchase of Common Stock | -3.00M | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 3.00M | 0.00 | 42.00M | -- | -- |
| Cash from Financing | 13.00K | 19.00K | 42.00M | 12.00K | 0.00 |
| Foreign Exchange rate Adjustments | -28.00K | -1.00K | -8.00K | 8.00K | -98.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.17M | -20.70M | 13.37M | -29.64M | 14.19M |
